Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ship Healthcare Holdings CoSHHPF 94 Debt-to-EBITDA is 0.50 as of Mar. 2026, which is 77% below its 10-year median of 2.17. GuruFocus rates SHHPF with a GF Score™ of 94/100 and a GF Value™ of $18.90. The stock has 3 warning signs investors should review. Among 468 Medical Devices & Instruments companies, Ship Healthcare Holdings Co ranks better than 57.69% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Ship Healthcare Holdings Co's Debt-to-EBITDA or its related term are showing as below:
SHHPF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.99 Med: 2.17 Max: 3.05
Current: 0.99
During the past 13 years, the highest Debt-to-EBITDA Ratio of Ship Healthcare Holdings Co was 3.05. The lowest was 0.99. And the median was 2.17.
SHHPF's Debt-to-EBITDA is ranked better than 57.69% of 468
companies
in the Medical Devices & Instruments industry
Industry Median: 1.585
vs SHHPF: 0.99
Ship Healthcare Holdings Co (OTCPK:SHHPF) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Ship Healthcare Holdings Co Debt-to-EBITDA Related Terms
Ship Healthcare Holdings Co Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHHPF vs ISRG, BDX, MDLN: Debt-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Ship Healthcare Holdings Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ship Healthcare Holdings Co Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ship Healthcare Holdings Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ship Healthcare Holdings Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Ship Healthcare Holdings Co (SHHPF) has a Debt-to-EBITDA of 0.50 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Ship Healthcare Holdings Co. This is 77% below median its historical median of 2.17. Over the past decade, Ship Healthcare Holdings Co's Debt-to-EBITDA has ranged from 0.99 to 3.05. According to the industry distribution chart, Ship Healthcare Holdings Co ranks #198 out of 468 companies in the Medical Devices & Instruments industry, placing it in the top 42.3%.
Is Ship Healthcare Holdings Co's Debt-to-EBITDA too high?
Ship Healthcare Holdings Co's current Debt-to-EBITDA of 0.50 is 77% below median its 10-year median of 2.17. Over the past 10 years, this metric has ranged from a low of 0.99 to a high of 3.05. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.59. Ship Healthcare Holdings Co's value of 0.50 is 68.5% below this industry median. Based on the distribution chart, Ship Healthcare Holdings Co ranks #198 out of 468 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ship Healthcare Holdings Co has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Ship Healthcare Holdings Co's Debt-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ship Healthcare Holdings Co ranks #198 out of 468 companies for Debt-to-EBITDA. This puts Ship Healthcare Holdings Co in the upper half of its industry. The industry median Debt-to-EBITDA is 1.59. Ship Healthcare Holdings Co's value of 0.50 is 68.5% below this benchmark. Historically, Ship Healthcare Holdings Co's own Debt-to-EBITDA has ranged from 0.99 to 3.05 over the past decade. While the company's 10-year median is 2.17 vs. the industry median of 1.59, Ship Healthcare Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.59, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ship Healthcare Holdings Co's current Debt-to-EBITDA of 0.50 is 68.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Ship Healthcare Holdings Co. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ship Healthcare Holdings Co's current Debt-to-EBITDA is 0.50, which is 77% below median its own 10-year median of 2.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ship Healthcare Holdings Co stock overvalued right now?
Ship Healthcare Holdings Co (SHHPF) has a current Debt-to-EBITDA of 0.50. The stock's GF Value™ is $18.90, compared to a current price of $16.88 — trading 10.7% below its estimated fair value. The current Debt-to-EBITDA is 0.50, which is 77% below median its 10-year median of 2.17 and 68.5% below the Medical Devices & Instruments industry median of 1.59. Ship Healthcare Holdings Co's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Ship Healthcare Holdings Co (SHHPF), the current Debt-to-EBITDA is 0.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ship Healthcare Holdings Co (SHHPF) Overvalued in 2026?
Based on GuruFocus' analysis, Ship Healthcare Holdings Co stock appears to be undervalued.
The current stock price of $16.88 is trading 10.7% below its estimated GF Value™ of $18.90.
Key valuation signals for SHHPF:
Debt-to-EBITDA: 0.50 (77% below median its 10-year median of 2.17)
GF Value™: $18.90 vs. price of $16.88 (10.7% below fair value)
Industry Position: 68.5% below the Medical Devices & Instruments median (#198 of 468)
No single metric tells the full story. See the SHHPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ship Healthcare Holdings Co Ltd is a Japanese company engaged in the healthcare business. The company's business is organized into various segments, which include Total Pack Produce Project, Medical Supply, Life Care, Dispensing Pharmacy, and Others. Through its segments, it mainly offers consulting, sales, and leasing services related to medical equipment, sale of medical materials and supplies, private nursing home services, distribution of pharmaceutical products.
94GF Score
Get the complete analysis for SHHPF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHHPF has been successfully added to your 
